BANOPHEN- diphenhydramine hcl tablet, film coated

Banophen by

Drug Labeling and Warnings

Banophen by is a Prescription medication manufactured, distributed, or labeled by Health Department, Oklahoma State. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

WHEN USING

marked drowsiness may occur
avoid alcoholic beverages
alcohol, sedatives, and tranquilizers may increase drowsiness
use caution when driving a motor vehicle or operating machinery
excitability may occur, especially in children

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

BANOPHEN 
diphenhydramine hcl tablet, film coated

Product Information
Product Type	HUMAN PRESCRIPTION DRUG	Item Code (Source)	NDC: 83112-555(NDC:0904-5551)
Route of Administration	ORAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
DIPHENHYDRAMINE HYDROCHLORIDE (UNII: TC2D6JAD40) (DIPHENHYDRAMINE - UNII:8GTS82S83M)	DIPHENHYDRAMINE HYDROCHLORIDE	25 mg

Product Characteristics
Color	pink	Score	no score
Shape	OVAL	Size	11mm
Flavor		Imprint Code	44;329
Contains

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 83112-555-59	1 in 1 PACKET; Type 0: Not a Combination Product	01/31/2025

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
unapproved drug other		01/31/2025

Labeler - Health Department, Oklahoma State (143673015)

Registrant - Health Department, Oklahoma State (143673015)

Establishment
Name	Address	ID/FEI	Business Operations
Health Department, Oklahoma State		143673015	repack(83112-555)